Pub Date : 2024-09-24DOI: 10.1007/s00203-024-04127-9
Praveen Belagal
The originally identified transcription-defective fitA76 temperature-sensitive (Ts) mutation defined an allele of pheS. Both fitA/pheS and fitB/pheT were previously proposed to function as transcription factors. Sequencing pheS region of the fitA76 mutant revealed the same G293→A293 transition found in the translation-defective pheS5 mutant. It was subsequently found that fitA76 harbored a second mutation (fit95) in addition to pheS5 mutation. The fit95 was found to be Ts on –salt media but was found unstable. In this investigation, genetic, physiological and molecular characterization of the fit95 mutation was carried out. The fit95 was genetically re-separated from the pheS5 mutation present in the fitA76 mutant and the same was subsequently mobilized into multiple genetic backgrounds to study its phenotypic modulations by altering the medium and supplements. Based on genetic studies, the unstable –salt Ts phenotype of the fit95 could be stabilized by the presence of rpoB201 mutation. Addition of glucose enhanced Ts phenotype in the presence of rpoB201 mutation, but citrate completely alleviated the Ts phenotype. Further, by series of complementation analyses and molecular cloning, the identity of fit95 was revealed as pheT gene which is part of pheST operon.
{"title":"Genetic and molecular characterization of fit95 mutation of Escherichia coli: evidence that fit95 is an allele of pheT","authors":"Praveen Belagal","doi":"10.1007/s00203-024-04127-9","DOIUrl":"10.1007/s00203-024-04127-9","url":null,"abstract":"<div><p>The originally identified transcription-defective <i>fitA76</i> temperature-sensitive (Ts) mutation defined an allele of <i>pheS</i>. Both <i>fitA</i>/<i>pheS</i> and <i>fitB</i>/<i>pheT</i> were previously proposed to function as transcription factors. Sequencing <i>pheS</i> region of the <i>fitA76</i> mutant revealed the same G<sub>293</sub>→A<sub>293</sub> transition found in the translation-defective <i>pheS5</i> mutant. It was subsequently found that <i>fitA76</i> harbored a second mutation (<i>fit95</i>) in addition to <i>pheS5</i> mutation. The <i>fit95</i> was found to be Ts on –salt media but was found unstable. In this investigation, genetic, physiological and molecular characterization of the <i>fit95</i> mutation was carried out. The <i>fit95</i> was genetically re-separated from the <i>pheS5</i> mutation present in the <i>fitA76</i> mutant and the same was subsequently mobilized into multiple genetic backgrounds to study its phenotypic modulations by altering the medium and supplements. Based on genetic studies, the unstable –salt Ts phenotype of the <i>fit95</i> could be stabilized by the presence of <i>rpoB201</i> mutation. Addition of glucose enhanced Ts phenotype in the presence of <i>rpoB201</i> mutation, but citrate completely alleviated the Ts phenotype. Further, by series of complementation analyses and molecular cloning, the identity of <i>fit95</i> was revealed as <i>pheT</i> gene which is part of <i>pheST</i> operon.</p></div>","PeriodicalId":8279,"journal":{"name":"Archives of Microbiology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142307042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A novel bacterium, designated as strain LOR1-02T and isolated from a lichen sample collected from Kham Riang Subdistrict, Kantharawichai District, Maha Sarakham Province, Thailand, underwent thorough investigation utilizing a polyphasic taxonomic approach. Strain LOR1-02T demonstrated growth within a temperature range of 20–42 °C (optimal at 30 °C), pH range of 5.0–7.5 (optimal at pH 7.0), and tolerance to 4.0% (w/v) NaCl. Phylogenetic analysis revealed its close relation to Paracraurococcus ruber JCM 9931T, with a 16S rRNA gene sequence similarity of 97.16%, placing it within the genus Paracraurococcus. The approximate genome size of strain LOR1-02T was determined to be 8.6 Mb, with a G + C content of 70.9 mol%. Additionally, ANIb, ANIm, and AAI values between the whole genomes of strain LOR1-02T and type strains were calculated as 82.6–83.4%, 86.1–86.8%, and 81.4–82.2%, respectively, while the dDDH value was determined to be 26.3–28.5% (C.I. 24.0–31.0%). The predominant fatty acids detected were C18:1ω7c and/or C18:1ω6c, C16:0, and C18:12OH. The major ubiquinone identified was Q-10, and the polar lipids included phosphatidylglycerol, phosphatidylethanolamine, phosphatidylcholine, diphosphatidylglycerol, along with unidentified phosphoaminolipid, lipids, and an amino lipid. Based on comprehensive phenotypic, chemotaxonomic, and genotypic characterization, it is concluded that strain LOR1-02T represents a novel species within the genus Paracraurococcus, for which the name Paracraurococcus lichenis sp. nov. is proposed. The type strain designation is LOR1-02T (= JCM 33121T = NBRC 112776T = TISTR 2503T).
{"title":"Paracraurococcus lichenis sp. nov., isolated from lichen in Thailand","authors":"Engkarat Kingkaew, Shingo Kato, Takao Iino, Takashi Itoh, Moriya Ohkuma, Wongsakorn Phongsopitanun, Somboon Tanasupawat","doi":"10.1007/s00203-024-04129-7","DOIUrl":"10.1007/s00203-024-04129-7","url":null,"abstract":"<div><p>A novel bacterium, designated as strain LOR1-02<sup>T</sup> and isolated from a lichen sample collected from Kham Riang Subdistrict, Kantharawichai District, Maha Sarakham Province, Thailand, underwent thorough investigation utilizing a polyphasic taxonomic approach. Strain LOR1-02<sup>T</sup> demonstrated growth within a temperature range of 20–42 °C (optimal at 30 °C), pH range of 5.0–7.5 (optimal at pH 7.0), and tolerance to 4.0% (w/v) NaCl. Phylogenetic analysis revealed its close relation to <i>Paracraurococcus ruber</i> JCM 9931<sup>T</sup>, with a 16S rRNA gene sequence similarity of 97.16%, placing it within the genus <i>Paracraurococcus</i>. The approximate genome size of strain LOR1-02<sup>T</sup> was determined to be 8.6 Mb, with a G + C content of 70.9 mol%. Additionally, ANIb, ANIm, and AAI values between the whole genomes of strain LOR1-02<sup>T</sup> and type strains were calculated as 82.6–83.4%, 86.1–86.8%, and 81.4–82.2%, respectively, while the dDDH value was determined to be 26.3–28.5% (C.I. 24.0–31.0%). The predominant fatty acids detected were C<sub>18:1</sub><i>ω</i>7c and/or C<sub>18:1</sub><i>ω</i>6c, C<sub>16:0</sub>, and C<sub>18:1</sub>2OH. The major ubiquinone identified was Q-10, and the polar lipids included phosphatidylglycerol, phosphatidylethanolamine, phosphatidylcholine, diphosphatidylglycerol, along with unidentified phosphoaminolipid, lipids, and an amino lipid. Based on comprehensive phenotypic, chemotaxonomic, and genotypic characterization, it is concluded that strain LOR1-02<sup>T</sup> represents a novel species within the genus <i>Paracraurococcus</i>, for which the name <i>Paracraurococcus lichenis</i> sp. nov. is proposed. The type strain designation is LOR1-02<sup>T</sup> (= JCM 33121<sup>T</sup> = NBRC 112776<sup>T</sup> = TISTR 2503<sup>T</sup>).</p></div>","PeriodicalId":8279,"journal":{"name":"Archives of Microbiology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142307043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-23DOI: 10.1007/s00203-024-04133-x
Meetali Girdhar, Aparajita Sen, Arti Nigam, Jyoti Oswalia, Sachin Kumar, Rashi Gupta
Antibiotic resistance has emerged as a global threat, rendering the existing conventional treatment strategies ineffective. In view of this, antimicrobial peptides (AMPs) have proven to be potent alternative therapeutic interventions with a wide range of applications in clinical health. AMPs are small peptides produced naturally as a part of the innate immune responses against a broad range of bacterial, fungal and viral pathogens. AMPs present a myriad of advantages over traditional antibiotics, including their ability to target multiple sites, reduced susceptibility to resistance development, and high efficacy at low doses. These peptides have demonstrated notable potential in inhibiting microbes resistant to traditional antibiotics, including the notorious ESKAPE pathogens, recognized as the primary culprits behind nosocomial infections. AMPs, with their multifaceted benefits, emerge as promising candidates in the ongoing efforts to combat the escalating challenges posed by antibiotic resistance. This in-depth review provides a detailed discussion on AMPs, encompassing their classification, mechanism of action, and diverse clinical applications. Focus has been laid on combating newly emerging drug-resistant organisms, emphasizing the significance of AMPs in mitigating this pressing challenge. The review also illuminates potential future strategies that may be implemented to improve AMP efficacy, such as structural modifications and using AMPs in combination with antibiotics and matrix-inhibiting compounds.